HI-Blog

Participants offered feedback to DOH staff questions related to their medical cannabis testing requirements and then posed questions of their own to officials.

Officials outlined a transition period to take on accreditation authority in parallel with revising standards, including method approval and when enforcement of new standards would start.

Attendees had many suggestions and questions for WSLCB staff regarding draft rules for medically endorsed retailers, with emphasis around expected levels of enforcement.

After hearing two cannabis bills on Wednesday, lawmakers had increasingly busy calendars on Thursday and through the following mid-week to meet the next policy committee deadline.

A bill requiring development of training, mandatory signage, and medical interventions related to “high THC” cannabis was considered, and subsequently recommended, by a fiscal committee.

Lab representatives and other stakeholders pointed out discrepancies, redundancies, and costs related to proposed lab quality standards leading staff to ultimately choose to rework the rules.

The board voted to open rulemaking to implement social equity program changes and then heard public remarks related to the grant programs and transparency of the equity process.

A public hearing on cannabinoid legislation had a mix of support from public officials and prevention groups, as well as opposition/other remarks from hemp and cannabis interests.

The board reviewed social equity applicant webinars, denied one petition before opening rulemaking based on a different one, and heard feedback criticizing the quality of their data.